» Articles » PMID: 19812966

Neuromodulation with Pleiotropic and Multimodal Drugs -- Future Approaches to Treatment of Neurological Disorders

Overview
Specialty Neurosurgery
Date 2009 Oct 9
PMID 19812966
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Neurologists are confronted with an ever-growing amount of new information regarding the intimate processes taking place in both normal and pathological brains. Concepts like neuroprotection, neurotrophicity, or anoikis and their clinical utility may be of dazzling complexity. This paper briefly reviews some of the mechanisms involved in the pathogenesis of neurological diseases and current therapies. Since it is becoming more and more clear that using neuroprotective molecule with only one mechanism of action in disease treatment is a utopist idea, the research and use of multimodal drugs should be encouraged.It is not easy to find good therapeutic approaches to neurological disorders, especially if we do not have a deep understanding of all the basic endogenous biological processes, pathophysiological processes, and the links between them.

Citing Articles

A retrospective study of Cerebrolysin in patients with moderate to severe traumatic brain injury: Cognitive and functional outcomes.

Soto C, Salinas P, Munoz D, Olivares S, Gonzalez J, Saez V J Med Life. 2023; 16(7):1017-1021.

PMID: 37900065 PMC: 10600656. DOI: 10.25122/jml-2023-0125.


Extended Poststroke Rehabilitation Combined with Cerebrolysin Promotes Upper Limb Motor Recovery in Early Subacute Phase of Rehabilitation: A Randomized Clinical Study.

Mitrovic S, Konstantinovic L, Jerkovic V, Dedijer-Dujovic S, Djordjevic O Medicina (Kaunas). 2023; 59(2).

PMID: 36837492 PMC: 9958781. DOI: 10.3390/medicina59020291.


Weak Ultrasound Contributes to Neuromodulatory Effects in the Rat Motor Cortex.

Chu P, Huang C, Chang P, Chen R, Chen K, Hsieh T Int J Mol Sci. 2023; 24(3).

PMID: 36768901 PMC: 9917173. DOI: 10.3390/ijms24032578.


Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials.

Strilciuc S, Vecsei L, Boering D, Praznikar A, Kaut O, Riederer P Pharmaceuticals (Basel). 2021; 14(12).

PMID: 34959697 PMC: 8708612. DOI: 10.3390/ph14121297.


Current Synthesis and Systematic Review of Main Effects of Calf Blood Deproteinized Medicine (Actovegin) in Ischemic Stroke.

Firan F, Romila A, Onose G Int J Mol Sci. 2020; 21(9).

PMID: 32365943 PMC: 7246744. DOI: 10.3390/ijms21093181.